PsyBio Therapeutics Retains KCSA Strategic Communications for Investor Relations Services Apr 9, 2021
Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness Mar 25, 2021
PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin Mar 23, 2021